Answers are grounded in this paper and cite their sources.
Demonstrates branched-chain-amino-acid profiling in vivo using hyperpolarization techniques, implying new cancer research avenues.
Hyperpolarized 1 3 C magnetic resonance imaging (MRI) is the only method to image metabolic fluxes in real time, non‐invasively, and in vivo. To date, however, most studies have used [1‐ 1 3 C]pyruvate and dynamic nuclear polarization (dDNP). Here, we establish efficient hyperpolarization (HP) of protio and partially‐deuterated [1‐ 1 3 C]ketoisocaproate (KIC) using Spin‐Lock‐Induced‐Crossing‐Signal Amplification by Reversible Exchange (SLIC‐SABRE), a high‐throughput, uncomplex and low‐cost method based on parahydrogen. We demonstrate 13 C polarization up to ≈28% and T 1 relaxation times > 200 s at 1 T in methanol‐d 4 . A rapid purification procedure allowed us to obtain biocompatible formulations with ≈11% 13 C polarization at the time of injection, sufficient for in cellulo and in vivo studies. We found that branched‐chain‐amino‐acid transaminase (BCAT) activity leads to HP [1‐ 1 3 C]leucine formation exclusively in BCAT1‐high MDA‐MB231 breast‐cancer cells, but not in BCAT1‐low MCF7 or PyB6 cells. In a proof‐of‐concept in vivo experiment, 13 C magnetic resonance spectroscopy imaging of the healthy mouse brain detected [1‐ 13 C]leucine formation after intravenous injection of SABRE [1‐ 13 C]KIC‐d 2 . Our results demonstrate that [1‐ 13 C]KIC‐d 2 provides a sensitive readout of BCAT1‐dependent metabolism and that SLIC‐SABRE can rapidly generate this probe for 13 C MRI, extending accessible parahydrogen‐based hyperpolarization to amino‐acid pathways relevant to cancer biology and chemoresistance.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: